Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2005-03-15
2005-03-15
Canella, Karen A. (Department: 1642)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S325000, C435S252300, C435S254110, C536S023500
Reexamination Certificate
active
06867016
ABSTRACT:
A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as CS141 and transcribed from GI tract tissue, is described. These sequences are useful for the detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the GI tract, such as GI tract cancer. Also provided are antibodies which specifically bind to CS141-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific CS141 polypeptide, which molecules are useful for the therapeutic treatment of GI tract diseases, tumors or metastases.
REFERENCES:
patent: 5733748 (1998-03-01), Yu et al.
patent: 5994529 (1999-11-01), Feuerstein et al.
patent: WO 9515493 (1995-06-01), None
patent: WO 9520681 (1995-08-01), None
patent: 9630389 (1996-10-01), None
patent: 9639419 (1996-12-01), None
Oka et al, Cancer Research, 1993, vol. 53, pp. 1696-1701.*
Lazar et al, “Transforming Growth Factor alpha: Mutation of Aspartic Acid 47 and Leucine 48 . . . ”, Mol. Cell Biol., vol. 8, pp. 1247-1252, Mar. 1988.*
Burgess et al, “Possible Dissociation of the Heparin-binding and the Mitogenic Activities of the Heparin-binding Growth Factor-1 . . . ”, J of Cell Biol., vol. 111, pp. 2129-2138, Nov. 1990.*
Van de Vijver et al, “Amplification of the neu oncogene in human mammary tumors . . . ”, Molecular and Cellular Biology, vol. 7, pp. 2019-2023, May 1987.*
Rajkumar et al, “Diagnostic Valu of albumin Gene Expression in Liver tumors”, May Clinic Proceedings, vol. 73, pp. 533-536, Jun. 1998.*
Seq Search Results Seq ID No.:24.*
p. 167 1994-1995 Promega Catalog.*
Bennett, “p53 Alterations in Progenitor Lesions of the Bronchus, Esophagus, Oral Cavity and Colon,”Cancer Detection and Prevention 19(6):503-511 (1993).
Bione et al., “Transcriptional Organization of a 450-kb Region of the Human X Chromosome in Xq28,”Proc. Natl. Acad. Sci. USA 90(23):10977-10981 (1993).
Bione et al., sequence annotation, mRNA for 2.19 gene of human X chromosome in Xq28 (1995).
Davidson et al., “Detection of Occult Nodal Metastases in Patients With Colorectal Carcinoma,”Cancer 65:967-970 (1990).
Fu et al., “E2a-Pbx1 Induces Aberrant Expression of Tissue-Specific and Developmentally Regulated Genes When Expressed in NIH 3T3 Fibroblast,”Molecular and Cellular Biology 17:1503-1512 (1997).
Gerard et al., “Specific Detection of Carcinoembryonic Antigen-Expressing Tumor Cells in Bone Marrow Aspirates by Polymerase Chain Reaction,”J. of Clinical Oncology 12(4):725-729 (1994).
Jacobs et al., “Clinical Use of Tumor Markers in Oncology,”Curr. Probl. Cancer, p. 299 Nov./Dec. (1994).
Katz et al., “Molecular Staging of Prostate Cancer With the Use of an Enhanced Reverse transcriptase-PCR Assay,”Urology 33(6):765-775 (1994).
Lange et al., “Serum Prostate-Specific Antigen: Its use In Diagnosis and Management of Prostate Cancer,”Supp. to Urology 33(6):13-17 (1989).
Mansi et al., “Detection of Tumor Cells in Bone Marrow of Patients With Prostatic Carcinoma by Immunocytochemical Techniques,”J. of Urology 139:545-548 (1988).
Matsumura et al., “Cancer Diagnosis by Detection of New Abnormalities in Splicing of CD44 Gene Products in Bladder Tumours and Urine Cell Sediments,”J. Pathol. Supp. 175:108A (1995).
Accession No. X87193, “H. Sapiens mRNA for 2.19 Gene,” Jun. 2, 1995.
Schwartz, M. K., “Current status of tumour markers”;J. of Clin.&Lab. Investigation, 55:5-14 (1995).
Hillier, L., et al., “The WashU-Merck EST Project”, Abstract XP002073212, (1996).
Billing-Medel Patricia A.
Cohen Maurice
Colpitts Tracey L.
Friedman Paula N.
Gordon Julian
Abbott Laboratories
Canella Karen A.
Goller Mimi C.
LandOfFree
Reagents and methods useful for detecting diseases of the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reagents and methods useful for detecting diseases of the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reagents and methods useful for detecting diseases of the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3435985